CVRx (CVRX) Cash from Investing Activities (2020 - 2026)
CVRx's quarterly Cash from Investing Activities came in at -$122000.0 in Q1 2026, down 7.02% year-on-year from -$131207.5 in Q1 2025, and down 79.41% quarter-over-quarter from -$68000.0 in Q4 2025.
CVRx has reported Cash from Investing Activities for 7 years, with the latest figure at -$122000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 7.02% year-over-year to -$122000.0; the trailing twelve-month figure through Mar 2026 stood at -$588000.0 (down 5.38% YoY), and the FY2025 full-year result was -$580000.0, up 57.38% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$122000.0, down from -$68000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$37000.0 in Q3 2024, with the low at -$917000.0 in Q1 2024.
- Average Cash from Investing Activities over 5 years is -$196411.8, with a median of -$122000.0 recorded in 2026.
- Peak annual rise in Cash from Investing Activities reached 87.57% in 2025, while the deepest fall reached 697.3% in 2025.
- Tracing CVRX's Cash from Investing Activities over 5 years: stood at -$79000.0 in 2022, then plunged by 113.92% to -$169000.0 in 2023, then soared by 69.23% to -$52000.0 in 2024, then tumbled by 30.77% to -$68000.0 in 2025, then tumbled by 79.41% to -$122000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$122000.0 (Q1 2026), -$68000.0 (Q4 2025), and -$295000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn | -122,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Dec 31, 2025 | -68,000.00 |
| Dec 31, 2025 | -68,000.00 |
| Sep 30, 2025 | -295,000.00 |
| Sep 30, 2025 | -295,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Mar 31, 2025 | -114,000.00 |
| Mar 31, 2025 | -114,000.00 |
| Dec 31, 2024 | -52,000.00 |
| Dec 31, 2024 | -52,000.00 |
| Sep 30, 2024 | -37,000.00 |
| Sep 30, 2024 | -37,000.00 |
| Jun 30, 2024 | -355,000.00 |
| Jun 30, 2024 | -355,000.00 |
| Mar 31, 2024 | -917,000.00 |
| Mar 31, 2024 | -917,000.00 |
| Dec 31, 2023 | -169,000.00 |
| Dec 31, 2023 | -169,000.00 |
| Sep 30, 2023 | -39,000.00 |
| Sep 30, 2023 | -39,000.00 |
| Jun 30, 2023 | -143,000.00 |
| Jun 30, 2023 | -143,000.00 |
| Mar 31, 2023 | -240,000.00 |
| Mar 31, 2023 | -240,000.00 |
| Dec 31, 2022 | -79,000.00 |
| Dec 31, 2022 | -79,000.00 |
| Sep 30, 2022 | -264,000.00 |
| Sep 30, 2022 | -264,000.00 |
| Jun 30, 2022 | -49,000.00 |
| Jun 30, 2022 | -49,000.00 |
| Mar 31, 2022 | -293,000.00 |
| Mar 31, 2022 | -293,000.00 |
| Dec 31, 2021 | -538,000.00 |
| Dec 31, 2021 | -538,000.00 |
| Sep 30, 2021 | -165,000.00 |
| Sep 30, 2021 | -165,000.00 |
| Jun 30, 2021 | -379,000.00 |
| Jun 30, 2021 | -379,000.00 |
| Mar 31, 2021 | -101,000.00 |
| Mar 31, 2021 | -101,000.00 |
| Dec 31, 2020 | -101,000.00 |
| Dec 31, 2020 | -101,000.00 |
| Sep 30, 2020 | -118,000.00 |
| Sep 30, 2020 | -118,000.00 |